Loring Wolcott & Coolidge Fiduciary Advisors’s ResMed RMD Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.31K	Hold	17	–	–	﹤0.01%	553
2026 Q1	$3.89K	Hold	17	–	–	﹤0.01%	545
2025 Q4	$4.34K	Hold	17	–	–	﹤0.01%	519
2025 Q3	$4.51K	Hold	17	–	–	﹤0.01%	516
2025 Q2	$4.39K	Hold	17	–	–	﹤0.01%	501
2025 Q1	$3.65K	Hold	17	–	–	﹤0.01%	514
2024 Q4	$4.33K	Hold	17	–	–	﹤0.01%	514
2024 Q3	$4.06K	Hold	17	–	–	﹤0.01%	531
2024 Q2	$3.52K	Hold	17	–	–	﹤0.01%	528
2024 Q1	$3.07K	Hold	17	–	–	﹤0.01%	544
2023 Q4	$3.23K	Hold	17	–	–	﹤0.01%	530
2023 Q3	$2.55K	Hold	17	–	–	﹤0.01%	580
2023 Q2	$3.71K	Buy	+17	New	+$3.79K	﹤0.01%	590
2021 Q3	–	Sell	-13	Closed	-$3K	–	901
2021 Q2	$3K	Buy	+13	New	+$2.73K	﹤0.01%	809
2016 Q3	–	Sell	-485	Closed	-$31K	–	638
2016 Q2	$31K	Sell	485 -435	-47%	-$25.6K	﹤0.01%	442
2016 Q1	$53K	Sell	920 -365	-28%	-$20.7K	﹤0.01%	383
2015 Q4	$69K	Hold	1,285	–	–	﹤0.01%	377
2015 Q3	$72K	Hold	1,285	–	–	﹤0.01%	387
2015 Q2	$72K	Hold	1,285	–	–	﹤0.01%	387
2015 Q1	$92K	Sell	1,285 -515	-29%	-$33.5K	﹤0.01%	370
2014 Q4	$101K	Hold	1,800	–	–	﹤0.01%	358
2014 Q3	$89K	Hold	1,800	–	–	﹤0.01%	352
2014 Q2	$91K	Hold	1,800	–	–	﹤0.01%	367
2014 Q1	$80K	Buy	+1,800	New	+$80.9K	﹤0.01%	366

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's RMD Position: Q2 2026 in Review

Loring Wolcott & Coolidge Fiduciary Advisors held its ResMed (RMD) position steady in Q2 2026 at 17 shares worth $3.31K. The position accounts for ﹤0.01% of the portfolio, ranked #553.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in RMD in Q1 2014 and has held it in 24 quarters since. The position peaked at $101K in Q4 2014. 448 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Loring Wolcott & Coolidge Fiduciary Advisors held 17 shares of ResMed worth $3.31K as of Q2 2026.
Loring Wolcott & Coolidge Fiduciary Advisors left its ResMed share count unchanged in Q2 2026.
ResMed made up ﹤0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #553 holding.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in ResMed in Q1 2014 and has held it in 24 quarters since.
Loring Wolcott & Coolidge Fiduciary Advisors's ResMed position peaked at $101K in Q4 2014.
448 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.